Bio-pharma Market Research Report by Region (Europe, Asia Pacific, North America and South America), Type and Application, Forecast to 2028 (Updated Version Available)
Date: Mar, 2021 | 164 Pages | Report ID: MRI_52576
Bio-pharma Market Research Report by Region (Europe, Asia Pacific, North America and South America), Type and Application, Forecast to 2028 (Updated Version Available)
ID : MRI52576 | Date : Mar, 2021 | Pages :
164 | Region : Global |
Publisher : MRI
The Bio-pharma market report provides a detailed analysis of global market size, value chain optimization, segmentation market growth, market share, competitive Landscape, regional and country-level market size, sales analysis, impact of domestic and global market players, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Bio-pharma market size is expected to gain market growth in the forecast period of 2023 to 2028, with a CAGR of xx%% in the forecast period of 2023 to 2028 and will expected to reach USD xx million by 2028, from USD xx million in 2020.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
Competitive Landscape and Bio-pharma Market Share Analysis
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Pfizer
F. Hoffmann-La Roche AG
Johnson & Johnson Services
Sanofi, Amgen
AbbVie
Merck & Co.
Biogen Idec
Bayer AG
Eli Lilly and Company
Novartis AG GlaxoSmithKline Plc
Bristol-Myers Squibb Company
AstraZeneca PLC
Abbott Laboratories
Product Type Coverage (Market Size Forecast, Major Company of Product Type etc.):
Monoclonal Antibodies
Recombinant Proteins
Granulocyte-Colony Stimulating Factor (G-CSF)
Interferons
Recombinant Human Insulin
Erythropoietin
Vaccines
Growth Hormones
Purified Proteins
Others
By Application
Metabolic Disorders
Oncology
Neurological Disorders
Cardiovascular Diseases
Inflammatory and Infectious Diseases
Others
Bio-pharma competitive landscape provides details by vendors, including company overview, company total revenue (financial), market potential, global presence, Bio-pharma sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Bio-pharma sales, revenue and market share for each player covered in this report.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Bio-pharma market presented in the report. This section sheds light on the sales growth of different regional and country-level Bio-pharma markets. For the historical and forecast period 2015 to 2028, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Bio-pharma market.
By Region:
North America
By Country (US, Canada, Mexico)
By Component
By System
By Application
Western Europe
By Country (Germany, UK, France, Italy, Spain, Rest of Western Europe)
By Component
By System
By Application
Eastern Europe
By Country (Russia, Turkey, Rest of Eastern Europe)
By Component
By System
By Application
Asia Pacific
By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
By Component
By System
By Application
Middle East
By Country (UAE, Saudi Arabia, Qatar, Iran, Rest of Middle East)
By Component
By System
By Application
Rest of the World
By Region (South America, Africa)
By Component
By System
By Application
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Bio-pharma market for the forecast period 2023 - 2028?
• What are the driving forces in the Bio-pharma market for the forecast period 2023 - 2028?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Bio-pharma industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
CHAPTER 1 MARKET OVERVIEW
1.1 Market Definition and Segment
1.1.1 Product Definition
1.1.2 Product Type
1.1.3 End-Use
1.1.4 Marketing Channel
1.2 Major Regions
1.2.1 Europe Market Size and Growth
Figure Europe Bio-pharma Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Bio-pharma Market Forecast and Growth Rate, 2020E-2026F (Million USD)
1.2.2 America Market Size and Growth
Figure America Bio-pharma Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Bio-pharma Market Forecast and Growth Rate, 2020E-2026F (Million USD)
1.2.3 Asia Market Size and Growth
Figure Asia Bio-pharma Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaBio-pharma Market Forecast and Growth Rate, 2020E-2026F (Million USD)
1.2.4 Oceania Market Size and Growth
Figure Oceania Bio-pharma Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Bio-pharma Market Forecast and Growth Rate, 2020E-2026F (Million USD)
1.2.5 Africa Market Size and Growth
Figure Africa Bio-pharma Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Bio-pharma Market Forecast and Growth Rate, 2020E-2026F (Million USD)
CHAPTER 2 GLOBAL MARKET SEGMENTATION
2.1 Global Production Overview
Table Global Bio-pharma Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Bio-pharma Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Bio-pharma Revenue by Type, 2015-2020 (Million USD)
Figure Global Bio-pharma Revenue Share by Type in 2020 (Million USD)
Table Global Bio-pharma Production Volume by Type, 2015-2020 (Volume)
Figure Global Bio-pharma Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Bio-pharma Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Bio-pharma Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Bio-pharma Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Bio-pharma Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Bio-pharma Consumption Value by Region, 2015-2020 (Million USD)
Table Global Bio-pharma Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 3 Europe MARKET SEGMENTATION
3.1 Europe Production Overview
Table Europe Bio-pharma Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Bio-pharma Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Bio-pharma Revenue by Type, 2015-2020 (Million USD)
Figure Europe Bio-pharma Revenue Share by Type in 2020 (Million USD)
Table Europe Bio-pharma Production Volume by Type, 2015-2020 (Volume)
Figure Europe Bio-pharma Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Bio-pharma Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Bio-pharma Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Bio-pharma Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Bio-pharma Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Bio-pharma Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Bio-pharma Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 4 AMERICA MARKET SEGMENTATION
4.1 America Production Overview
Table America Bio-pharma Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Bio-pharma Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Bio-pharma Revenue by Type, 2015-2020 (Million USD)
Figure America Bio-pharma Revenue Share by Type in 2020 (Million USD)
Table America Bio-pharma Production Volume by Type, 2015-2020 (Volume)
Figure America Bio-pharma Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Bio-pharma Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Bio-pharma Consumption Value Share by End-Use in 2020 (Million USD)
Table America Bio-pharma Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Bio-pharma Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Bio-pharma Consumption Value by Region, 2015-2020 (Million USD)
Table America Bio-pharma Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 5 ASIA MARKET SEGMENTATION
5.1 Asia Production Overview
Table Asia Bio-pharma Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Bio-pharma Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Bio-pharma Revenue by Type, 2015-2020 (Million USD)
Figure Asia Bio-pharma Revenue Share by Type in 2020 (Million USD)
Table Asia Bio-pharma Production Volume by Type, 2015-2020 (Volume)
Figure Asia Bio-pharma Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Bio-pharma Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Bio-pharma Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Bio-pharma Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Bio-pharma Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Bio-pharma Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Bio-pharma Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 6 OCEANIA MARKET SEGMENTATION
6.1 Oceania Production Overview
Table Oceania Bio-pharma Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Bio-pharma Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Bio-pharma Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Bio-pharma Revenue Share by Type in 2020 (Million USD)
Table Oceania Bio-pharma Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Bio-pharma Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Bio-pharma Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Bio-pharma Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Bio-pharma Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Bio-pharma Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Bio-pharma Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Bio-pharma Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 7 AFRICA MARKET SEGMENTATION
7.1 Africa Production Overview
Table Africa Bio-pharma Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Bio-pharma Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Bio-pharma Revenue by Type, 2015-2020 (Million USD)
Figure Africa Bio-pharma Revenue Share by Type in 2020 (Million USD)
Table Africa Bio-pharma Production Volume by Type, 2015-2020 (Volume)
Figure Africa Bio-pharma Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Bio-pharma Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Bio-pharma Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Bio-pharma Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Bio-pharma Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Bio-pharma Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Bio-pharma Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 8 GLOBAL MARKET FORECAST
8.1 Global Bio-pharma Production Forecast
Figure Global Bio-pharma Revenue and Growth Rate Forecast 2020E-2026F (Million USD)
Figure Global Bio-pharma Production Volume and Growth Rate Forecast 2020E-2026F (Volume)
8.2 Global Bio-pharma Forecast by Type
Table Global Bio-pharma Revenue by Type, 2020E-2026F (Million USD)
Figure Global Bio-pharma Revenue Share by Type in 2025 (Million USD)
Table Global Bio-pharma Production Volume by Type, 2020E-2026F (Volume)
Figure Global Bio-pharma Production Volume Share by Type in 2025 (Volume)
8.3 Global Bio-pharma Forecast by End-Use (2020E-2026F)
Table Global Bio-pharma Consumption Value by End-Use, 2020E-2026F (Million USD)
Figure Global Bio-pharma Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Bio-pharma Consumption Volume by End-Use, 2020E-2026F (Volume)
8.4 Global Bio-pharma Forecast by Region (2020E-2026F)
Table Global Bio-pharma Consumption Value by Region, 2020E-2026F (Million USD)
Figure Global Bio-pharma Consumption Value Share by Region in 2025 (Million USD)
Table Global Bio-pharma Consumption Volume by Region, 2020E-2026F (Volume)
Figure Global Bio-pharma Consumption Volume Share by Region in 2025 (Volume)
CHAPTER 9 GLOBAL MAJOR COMPANIES LIST
9.1 Pfizer
9.1.1 Pfizer Profile
Table Pfizer Overview List
9.1.2 Pfizer Products & Services
9.1.3 Pfizer Company Dynamics & News
9.1.4 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 F. Hoffmann-La Roche AG
9.2.1 F. Hoffmann-La Roche AG Profile
Table F. Hoffmann-La Roche AG Overview List
9.2.2 F. Hoffmann-La Roche AG Products & Services
9.2.3 F. Hoffmann-La Roche AG Company Dynamics & News
9.2.4 F. Hoffmann-La Roche AG Business Operation Conditions
Table Business Operation of F. Hoffmann-La Roche AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Johnson & Johnson Services
9.3.1 Johnson & Johnson Services Profile
Table Johnson & Johnson Services Overview List
9.3.2 Johnson & Johnson Services Products & Services
9.3.3 Johnson & Johnson Services Company Dynamics & News
9.3.4 Johnson & Johnson Services Business Operation Conditions
Table Business Operation of Johnson & Johnson Services (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Sanofi, Amgen
9.4.1 Sanofi, Amgen Profile
Table Sanofi, Amgen Overview List
9.4.2 Sanofi, Amgen Products & Services
9.4.3 Sanofi, Amgen Company Dynamics & News
9.4.4 Sanofi, Amgen Business Operation Conditions
Table Business Operation of Sanofi, Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 AbbVie
9.5.1 AbbVie Profile
Table AbbVie Overview List
9.5.2 AbbVie Products & Services
9.5.3 AbbVie Company Dynamics & News
9.5.4 AbbVie Business Operation Conditions
Table Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Merck & Co.
9.6.1 Merck & Co. Profile
Table Merck & Co. Overview List
9.6.2 Merck & Co. Products & Services
9.6.3 Merck & Co. Company Dynamics & News
9.6.4 Merck & Co. Business Operation Conditions
Table Business Operation of Merck & Co. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Biogen Idec
9.7.1 Biogen Idec Profile
Table Biogen Idec Overview List
9.7.2 Biogen Idec Products & Services
9.7.3 Biogen Idec Company Dynamics & News
9.7.4 Biogen Idec Business Operation Conditions
Table Business Operation of Biogen Idec (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Bayer AG
9.8.1 Bayer AG Profile
Table Bayer AG Overview List
9.8.2 Bayer AG Products & Services
9.8.3 Bayer AG Company Dynamics & News
9.8.4 Bayer AG Business Operation Conditions
Table Business Operation of Bayer AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Eli Lilly and Company
9.9.1 Eli Lilly and Company Profile
Table Eli Lilly and Company Overview List
9.9.2 Eli Lilly and Company Products & Services
9.9.3 Eli Lilly and Company Company Dynamics & News
9.9.4 Eli Lilly and Company Business Operation Conditions
Table Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 Novartis AG GlaxoSmithKline Plc
9.10.1 Novartis AG GlaxoSmithKline Plc Profile
Table Novartis AG GlaxoSmithKline Plc Overview List
9.10.2 Novartis AG GlaxoSmithKline Plc Products & Services
9.10.3 Novartis AG GlaxoSmithKline Plc Company Dynamics & News
9.10.4 Novartis AG GlaxoSmithKline Plc Business Operation Conditions
Table Business Operation of Novartis AG GlaxoSmithKline Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 Bristol-Myers Squibb Company
9.11.1 Bristol-Myers Squibb Company Profile
Table Bristol-Myers Squibb Company Overview List
9.11.2 Bristol-Myers Squibb Company Products & Services
9.11.3 Bristol-Myers Squibb Company Company Dynamics & News
9.11.4 Bristol-Myers Squibb Company Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 AstraZeneca PLC
9.12.1 AstraZeneca PLC Profile
Table AstraZeneca PLC Overview List
9.12.2 AstraZeneca PLC Products & Services
9.12.3 AstraZeneca PLC Company Dynamics & News
9.12.4 AstraZeneca PLC Business Operation Conditions
Table Business Operation of AstraZeneca PLC (Sales Revenue, Cost, Gross Margin)
9.13 Abbott Laboratories
9.13.1 Abbott Laboratories Profile
Table Abbott Laboratories Overview List
9.13.2 Abbott Laboratories Products & Services
9.13.3 Abbott Laboratories Company Dynamics & News
9.13.4 Abbott Laboratories Business Operation Conditions
Table Business Operation of Abbott Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
PART 10 MARKET COMPETITION
10.1 Key Company Market Share
Table Global Bio-pharma Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Bio-pharma Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Bio-pharma Sales Volume by Companies, 2015-2020E (Volume)
Table Global Bio-pharma Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Bio-pharma Market Concentration Ratio in 2020E
Figure America Bio-pharma Market Concentration Ratio in 2020E
Figure Asia Bio-pharma Market Concentration Ratio in 2020E
Figure Oceania Bio-pharma Market Concentration Ratio in 2020E
Figure Africa Bio-pharma Market Concentration Ratio in 2020E
PART 11 CORONAVIRUS IMPACT ON Bio-pharma INDUSTRY
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
PART 12 Bio-pharma INDUSTRY SUMMARY & CONCLUSION
Research Methodology
The Market Reports Insights offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.
Market Reports Insights are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
Well researched, expertise analysts, well organized, concrete and current topics delivered in time.
- President and CEO
Very helpful to understand overview of business status, by customers, categories, timeless, and regions. Able to build the future business strategy on the basis of research report. Validated and researched information of reports.
- Senior Manager, Product Development
We are very thankful to (company name) for detailed research report delivering in short period of time. Good market research Company really commendable.
- Senior Manager, Product Development
Excellent services, unique and very professional. The effort taken to make sure relevance to our requirements ensured the best possible outcome.
